NOXXON Announces Capital Increase of € 5.5 Million by Private Placement to Further Develop Its Business
(WorldNews Germany)

NOXXON Announces Capital Increase of € 5.5 Million by Private Placement to Further Develop Its Business 08 May 2020 21:00 CEST Company Name NOXXON ISN NL0012044762 Market Euronext Growth Symbol ALNOX Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today the successful completion of its capital increase by issuing new ordinary shares with exclusion of pre-emptive subscription rights, via a private placement to European investors through an accelerated bookbuilding process, for approximately € 5.5 million. `We would like to thank the new shareholders who...